Recalls / Brands / Norepinephrine Bitartrate
Norepinephrine Bitartrate
2 FDA drug recalls involving brand “Norepinephrine Bitartrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-01-23 | Class II | Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 2 | Baxter Healthcare Corporation |
| 2023-03-29 | Class III | Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-4 | SUN PHARMACEUTICAL INDUSTRIES INC |